Thoracic circumference: A new outcome measure in spinal muscular atrophy type 1?

被引:10
|
作者
Ropars, Juliette [1 ,2 ]
Barnerias, Christine [3 ]
Hully, Marie [3 ]
Chabaliere, Delphine [3 ]
Peudenier, Sylviane [1 ]
Barzic, Audrey [1 ]
Cros, Pierrick [1 ]
Desguerre, Isabelle [3 ]
机构
[1] CHRU Brest, Serv Pediat, 2 Ave Foch, F-29609 Brest, France
[2] INSERM, Lab Traitement Informat Med, U1101, Brest, France
[3] Hop Necker Enfants Malad, AP HP, Paris, France
关键词
Spinal muscular atrophy; Neuromuscular disorder; Outcome measure; Respiratory function; Disease progression; SHAM CONTROL; SMA; INFANTS; CARE; NUSINERSEN; CONSENSUS; SURVIVAL;
D O I
10.1016/j.nmd.2019.03.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Since respiratory insufficiency is the first cause of morbidity and mortality in spinal muscular atrophy type 1 (SMA 1), specific respiratory outcome measures are needed to evaluate changes and assess innovative therapies. In this study, thoracic circumference (TC) was used as a proxy for chest growth and an indirect measurement of respiratory function. The anthropometric parameters including TC and head circumference (HC) were evaluated from birth to 13 months in 19 infants with SMA 1 and 124 control infants. TC was significantly decreased in the SMA 1 group from the first weeks of life. The control group TC/HC ratio =1 ( 0.04), and was not found to be associated with age. By contrast, it decreased with time in all infants with SMA 1 and those with a TC/HC ratio <0.85 died within 3 months. TC is a simple measurement that provided an index of chest growth and was used as evidence of early, progressive respiratory failure and under-development of the rib-cage in SMA 1. The TC/HC ratio decreased in all patients over time, reflecting the progression of the disease suggesting that TC/HC ratio could be a new measure for SMA 1 for measuring disease severity and prognosis. (C) 2019 Elsevier B.Y. All rights reserved.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 50 条
  • [21] Outcome measures for pediatric spinal muscular atrophy
    Iannaccone, ST
    NEUROMUSCULAR DISORDERS, 2001, 11 (6-7) : 646 - 647
  • [22] Clinical Outcome Measures in Spinal Muscular Atrophy
    Montes, Jacqueline
    Gordon, Andrew M.
    Pandya, Shree
    De Vivo, Darryl C.
    Kaufmann, Petra
    JOURNAL OF CHILD NEUROLOGY, 2009, 24 (08) : 968 - 978
  • [23] Outcome measures for pediatric spinal muscular atrophy
    Iannaccone, ST
    ANNALS OF NEUROLOGY, 2001, 50 (03) : S127 - S127
  • [24] Outcome measures for pediatric spinal muscular atrophy
    Iannaccone, ST
    ARCHIVES OF NEUROLOGY, 2002, 59 (09) : 1445 - 1450
  • [25] Management of children with spinal muscular atrophy type 1 in Australia
    Tassie, Benjamin
    Isaacs, David
    Kilham, Henry
    Kerridge, Ian
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2013, 49 (10) : 815 - 819
  • [26] Combination molecular therapies for type 1 spinal muscular atrophy
    Harada, Yohei
    Rao, Vamshi K.
    Arya, Kapil
    Kuntz, Nancy L.
    DiDonato, Christine J.
    Napchan-Pomerantz, Galia
    Agarwal, Amit
    Stefans, Vikki
    Katsuno, Masahisa
    Veerapandiyan, Aravindhan
    MUSCLE & NERVE, 2020, 62 (04) : 550 - 554
  • [27] There are other ways to manage spinal muscular atrophy type 1
    Bach, JR
    CHEST, 2005, 127 (04) : 1463 - 1463
  • [28] The Natural History of Type 1 Spinal Muscular Atrophy in Taiwan
    Jones, C.
    Ou, S.
    Jong, Y.
    Ho, C.
    Lee, W.
    Lin, K.
    ANNALS OF NEUROLOGY, 2016, 80 : S366 - S367
  • [29] Effect of medications in Paediatric spinal muscular atrophy Type 1
    Chacko, A.
    Sly, P.
    Gauld, L.
    RESPIROLOGY, 2022, 27 : 182 - 183
  • [30] Sleep architecture in infants with spinal muscular atrophy type 1
    Verrill, Elisabetta
    Bruni, Olivier
    Pavone, Martino
    Ferri, Raffaele
    Navarra, Floriana
    Testa, Maria Beatrice Chiarini
    Soldini, Serena
    Cutrera, Renato
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44